JP2008540626A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540626A5
JP2008540626A5 JP2008511793A JP2008511793A JP2008540626A5 JP 2008540626 A5 JP2008540626 A5 JP 2008540626A5 JP 2008511793 A JP2008511793 A JP 2008511793A JP 2008511793 A JP2008511793 A JP 2008511793A JP 2008540626 A5 JP2008540626 A5 JP 2008540626A5
Authority
JP
Japan
Prior art keywords
group
compound
amino
substituted
carbocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008511793A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540626A (ja
Filing date
Publication date
Priority claimed from GB0510252A external-priority patent/GB0510252D0/en
Application filed filed Critical
Priority claimed from PCT/GB2006/001851 external-priority patent/WO2006123165A2/en
Publication of JP2008540626A publication Critical patent/JP2008540626A/ja
Publication of JP2008540626A5 publication Critical patent/JP2008540626A5/ja
Pending legal-status Critical Current

Links

JP2008511793A 2005-05-19 2006-05-19 医薬化合物 Pending JP2008540626A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68268705P 2005-05-19 2005-05-19
GB0510252A GB0510252D0 (en) 2005-05-19 2005-05-19 Pharmaceutical compounds
PCT/GB2006/001851 WO2006123165A2 (en) 2005-05-19 2006-05-19 Pyrimidine derivatives as hsp90 inhibitors

Publications (2)

Publication Number Publication Date
JP2008540626A JP2008540626A (ja) 2008-11-20
JP2008540626A5 true JP2008540626A5 (cg-RX-API-DMAC7.html) 2009-07-09

Family

ID=37431622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511793A Pending JP2008540626A (ja) 2005-05-19 2006-05-19 医薬化合物

Country Status (4)

Country Link
US (1) US20090215777A1 (cg-RX-API-DMAC7.html)
EP (1) EP2049497A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008540626A (cg-RX-API-DMAC7.html)
WO (1) WO2006123165A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006008880A1 (de) * 2006-02-27 2007-09-06 Merck Patent Gmbh Aminopyrimidinderivate
AR061185A1 (es) * 2006-05-26 2008-08-13 Chugai Pharmaceutical Co Ltd Compuestos heterociclicos como inhibidores de hsp90. composiciones farmaceuticas.
CL2008000467A1 (es) 2007-02-14 2008-08-22 Janssen Pharmaceutica Nv Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma
PE20090110A1 (es) 2007-03-01 2009-04-04 Chugai Pharmaceutical Co Ltd Compuestos macrociclicos derivados de amina como agentes inhibidores de hsp90
JP5529004B2 (ja) * 2007-03-27 2014-06-25 シンタ ファーマシューティカルズ コーポレーション Ｈｓｐ９０阻害剤として有用なトリアジノンおよびジアジノン誘導体
KR100965726B1 (ko) 2007-11-23 2010-06-24 재단법인서울대학교산학협력재단 피리미딘-2,4,6-트라이온 유도체를 함유하는 Ｈｓｐ９０억제제 및 이를 이용한 항암제
WO2009086277A1 (en) 2007-12-20 2009-07-09 Envivo Pharmaceuticals, Inc. Tetrasubstituted benzenes
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
JP2011523646A (ja) 2008-05-21 2011-08-18 アリアド・ファーマシューティカルズ・インコーポレイテッド キナーゼ阻害剤としてのリン誘導体
UY32582A (es) 2009-04-28 2010-11-30 Amgen Inc Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamífero
AU2012250517B2 (en) 2011-05-04 2016-05-19 Takeda Pharmaceutical Company Limited Compounds for inhibiting cell proliferation in EGFR-driven cancers
JP6469567B2 (ja) 2012-05-05 2019-02-13 アリアド・ファーマシューティカルズ・インコーポレイテッド Ｅｇｆｒ発動性がんの細胞増殖阻害用化合物
WO2014144715A1 (en) 2013-03-15 2014-09-18 Memorial Sloan-Kettering Cancer Center Hsp90-targeted cardiac imaging and therapy
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
EP3154547B1 (en) * 2014-06-13 2023-06-07 Yuma Therapeutics, Inc. Pyrimidine compounds and methods using the same
EP3194975A4 (en) 2014-09-17 2018-05-02 Memorial Sloan Kettering Cancer Center Hsp90-targeted inflammation and infection imaging and therapy
HRP20191327T1 (hr) * 2015-06-03 2019-11-01 Bristol Myers Squibb Co 4-hidroksi-3-(heteroaril)piridin-2-on apj agonisti za primjenju u liječenju kardiovaskularnih poremećaja
CN115845818B (zh) * 2022-12-13 2024-02-23 南京工业大学 一种木质素接枝n-[(二甲氨基)亚甲基]硫脲型重金属吸附剂及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7439359B2 (en) * 2000-11-02 2008-10-21 Sloan-Kettering Institute For Cancer Research Small molecule compositions for binding to hsp90
WO2003075828A2 (en) * 2002-03-11 2003-09-18 Zetiq Technologies Ltd. Compounds useful in the treatment of cancer
ES2273047T3 (es) * 2002-10-28 2007-05-01 Bayer Healthcare Ag Fenilaminopirimidinas sustituidas con heteroariloxi como inhibidores de rho-cinasa.

Similar Documents

Publication Publication Date Title
KR101247840B1 (ko) 아밀로이드 베타 조절제
NO20084832L (no) Pyrimidinderivater som P13K-inhibitorer
RU2485115C2 (ru) Производные пиримидина в качестве ингибиторов alk-5
ES2374451T3 (es) Bencimidazoles sustituidos como inhibidores de quinasa.
AU2005215918C1 (en) Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
HRP20140252T1 (hr) Derivati imidazola kao inhibitori kazeinske kinaze
CA2682483A1 (en) 3-imidazolyl-indoles for the treatment of proliferative diseases
SK90297A3 (en) 1,4,5-tri-substituted imidazole compounds, producing method thereof, pharmaceutical composition containing them and their use
MX2008013203A (es) Analogos de anilino-pirimidina fenilo y benzotiofeno.
US8022209B2 (en) Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor
EP1799652A1 (en) N-benzenesulfonyl substituted anilino-pyrimidine analogs
JP2006500348A5 (cg-RX-API-DMAC7.html)
KR20150135359A (ko) 브로모도메인-함유 단백질의 억제를 위한 방법 및 조성물
TW200800185A (en) Acid secretion inhibitor
KR20010108504A (ko) 치환 아졸
AU2014348422B2 (en) EBNA1 inhibitors and their method of use
JP2008538750A5 (cg-RX-API-DMAC7.html)
SG192769A1 (en) Amino-quinolines as kinase inhibitors
JP2004538260A (ja) 抗癌剤としてのサイクリン依存性キナーゼ阻害剤
MX2009006636A (es) Nuevos intermediarios y procesos utiles en la rpeparacion de {2-[1-(3,5-bis-trifluorometil-bencil)-5-piridin-4-il-1h-[1,2,3]tr iazol-4-il]-piridin-3-il}-(2-clorofenil)-metanona.
FI4161927T3 (fi) Spiroyhdisteitä melanokortiini-4-reseptorin antagonisteina ja niiden käyttöjä
EA019481B1 (ru) Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их
JP2016510810A5 (cg-RX-API-DMAC7.html)
JP2001039870A (ja) 片頭痛治療のための組み合わせ療法
WO2010138585A1 (en) Pyrimidinones as pde10 inhibitors